Photodynamic therapy rescue for subretinal fluid exacerbation after focal laser treatment in idiopathic central serous chorioretinopathy

Open Ophthalmology Journal

Volumn 5, Issue , 2011, Pages 6-9

  Leng, Theodore ^a   Sanislo, Steven R ^a   Jack, Robert L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Focal laser; Idiopathic central serous chorioretinopathy; Photodynamic therapy

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; DISEASE EXACERBATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DISEASE; RETINAL PIGMENT EPITHELIUM HYPERPIGMENTATION; SUBRETINAL FLUID; TREATMENT RESPONSE; HYPERPIGMENTATION; LOW LEVEL LASER THERAPY; OPHTHALMIC ARGON LASER; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; RETINA EXAMINATION; SUBRETINAL LEAKAGE; VISUAL ACUITY;

EID: 79955065845     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101105010006     Document Type: Article

References (13)

1. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47(5): 431-48.
2. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988; 72(11): 829-34.
3. Gass JD. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977 83(3 Pt 1): 456-67.
4. Landers MB, 3rd, Shaw HE, Jr, Anderson WB, Jr, Sinyai AJ. Argon laser treatment of central serous chorioretinopathy. Ann Ophthalmol 1977; 9(12): 1567-72.
5. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95(4): 457-66.
6. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003; 23(2): 235-7.
7. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006; 90(7): 869-74.
8. Valmaggia C, Niederberger H, Photodynamic therapy in the treatment of chronic central serous chorioretinopathy. Klin Monbl Augenheilkd 2006; 223(5): 372-5.
9. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23(3): 288-98.
10. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 2008; 115(10): 1756-65.
11. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010; 149(3): 441-6 e1-2.
12. Matsunaga H, Nangoh K, Uyama M, Nanbu H, Fujiseki Y, Takahashi K. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nippon Ganka Gakkai Zasshi 1995; 99(4): 460-8.
13. Simon P, Glacet-Bernard A, Binaghi M, Coscas G, Soubrane G. Choroidal neovascularization as a complication following laser treatment of central serous chorioretinopathy. J Fr Ophtalmol, 2001. 24(1): p. 64-8.